Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole exom sequencing

PROVIDER: PRJNA665131 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12696673_1.fastq.gz	Fastqsanger.gz
	SRR12696673_2.fastq.gz	Fastqsanger.gz
	SRR12696674.fastq.gz	Fastqsanger.gz
	SRR12696675.fastq.gz	Fastqsanger.gz
	SRR12696676.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

E0771 WXS

Project description:E0771 whole exom sequencing

| PRJEB30681 | ENA

SETD2 Mutations Do Not Contribute to Clonal Fitness in Response to Chemotherapy in Childhood B Acute Lymphoblastic Leukemia (ATAC-Seq)

Project description:To investigate the impact of SETD2 mutations on clonal fitness in B actue lymphoblastic leukemia we generated cells lines with SETD KO using CRISPR/Cas9 system. We then performed phenotypic based assays as well as gene expression profiling, mutation burden, and chromtain accessibilty analysis using data obtained from RNA-seq, Whole exom sequencing following drug traetment, and ATAC-seq.

2024-05-01 | GSE231721 | GEO

SETD2 Mutations Do Not Contribute to Clonal Fitness in Response to Chemotherapy in Childhood B Acute Lymphoblastic Leukemia (RNA-Seq)

2024-05-01 | GSE231720 | GEO

SETD2 Mutations Do Not Contribute to Clonal Fitness in Response to Chemotherapy in Childhood B Acute Lymphoblastic Leukemia (WES)

2024-05-01 | GSE231723 | GEO

Project description:Whole exom sequencing of a Lipoid proteinosis patient

| PRJNA803015 | ENA

a21f9dff-b035-4b35-93ce-27a4a467822b - samples

Project description:106 Whole Exom Sequencing (WXS) of CMML samples. Paired-end fastq are provided.

| EGAD00001007026 | EGA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Immortal Dnmt3a KO Hematopoietic Stem Cell exom sequencing

| PRJNA435713 | ENA

Project description:Exom Sequencing of U-2 OS Knock-In cells

| PRJNA677859 | ENA

MuSt multiomics

Project description:Multiomics of faecal samples collected from individuals in families with multiple cases of type 1 diabetes mellitus (T1DM) over 3 or 4 months. Metagenomic and metatranscriptomic sequencing and metaproteomics were carried out, as well as whole human genome sequencing. Phenotypic data is available.

2017-10-19 | MSV000081630 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data